Study did not meet the primary endpointPamrevlumab was generally safe and well tolerated Topline results from LELANTOS-2 Phase 3 study of pamrevlumab in ambulatory patients with DMD expected 3Q 2023 . | June 7, 2023
1. Patients with chronic upper limb spasticity post-stroke randomized to radial extracorporeal shock wave therapy (rESWT) had greater symptomatic and functional improvement than patients randomized to transcutaneous electrical nerve stimulation (TENS). Evidence Rating Level: 1 (Excellent) It is estimated that 43% of patients who survive a stroke experience upper limb spasticity, which can be functionally
Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial 1. Rivaroxaban is safe and effective for venous thromboembolism (VTE) prophylaxis post-bariatric surgery. 2. Similar efficacy and safety profiles were observed with 10 mg rivaroxaban daily for either 7 or 28 days. Evidence Rating Level: 1 (Excellent) Individuals
The first Arkansan and only second person in the world has received an innovative prosthetic hand, developed by researchers at the Institute for Integrative and Innovative Research (I³R).
taxis, and that s pretty much the way i live my life. but i think for anybody who s got upper limb issues, it s easy to handle. and let s be honest, it looks pretty cool. but for me, it s a bit of fun and i ll be sticking to my manual wheelchair for now. brilliant. that was martin dougan out and about on brighton beach, and that is it from us, from the royal college of physicians. we shall be back next week. thanks for watching. see you. hello. the next six to ten days look fairly benign all thanks to high pressure, so i think that a lot of places will be dry but there will still be